Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.53 |
| ▸ | CTSK | P43235 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2315919 | 0.89 | SIGMAR1 (0.58) | KMT2ASIGMAR1CYP2C19SMN1; SMN2ALDH1A1 | |
| SCHEMBL29527802 | 0.86 | CTSS (0.62) | CTSSCTSKKMT2AL3MBTL1MAOB | |
| SCHEMBL3957208 | 0.86 | SCN9A (0.58) | CTSSCTSKKMT2AMEN1SIGMAR1 | |
| SCHEMBL2311994 | 0.85 | MEN1 (0.52) | KMT2AMEN1SIGMAR1CYP2C19SMN1; SMN2 | |
| SCHEMBL915402 | 0.85 | KMT2A (0.65) | KMT2AMEN1SIGMAR1L3MBTL1MAOB | |
| SCHEMBL7403794 | 0.84 | UTS2R (0.55) | CTSKKMT2AMEN1SIGMAR1CYP2C19 | |
| SCHEMBL16789063 | 0.84 | BCHE (0.54) | CTSSCTSKKMT2AMEN1ALDH1A1 | |
| SCHEMBL21237658 | 0.82 | CTSS (0.58) | CTSSCTSKKMT2ASMN1; SMN2 | |
| SCHEMBL7568066 | 0.82 | HRH2 (0.61) | KMT2AMEN1CYP2C19SMN1; SMN2L3MBTL1 | |
| SCHEMBL9384147 | 0.82 | HRH2 (0.61) | KMT2AMEN1CYP2C19SMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090005364-A1 | Azole Derivatives With Antimuscarinic Activity | CHIESI FARMACEUTICI S.P.A. (IT) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005364-A1 | Azole Derivatives With Antimuscarinic Activity | CHRM2, CHRM3, CHRM1 | CTSS 3780/4885CTSK 3227/4885KMT2A 2595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.